For example, if a subset of autoreactive plasma cells are pathogenic in human SLE, and these cells require either BAFF or APRIL, like normal mouse plasma cells32, atacicept could be superior to belimumab. Here, TNFSF13B is linked to systemic lupus erythematosus.